Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: FxCO2 Laser
Total 0 results
Nothing found
Sponsors and Collaborators
BioNova Pharmaceuticals (Shanghai) LTD.
The Affiliated Hospital of Xuzhou Medical University
Shanghai GeneChem Co., Ltd.
Hungarian Dental Association
Vivid Pharma Inc.
Cogniciti
Salena Killion
Université de Genève (UNIGE)
Huisartspraktijk Handellaan
Impulse Dynamics, Inc.
Zhongda Hospital, Medical School, Southeast University
UNITI Consortium
Nutrabolt
Defence Services Medical Academy (DSMA), Myanmar
Health Information Technology Solutions (HITS) LLC
Pia Jaeger, MD, PhD
Smart Meter Corporation
HBSA
NERv Technology Inc
Ministry of Public Health, Cameroon
View Full List
Medical Conditions
Research Mentoring Skills
Alzheimer Disease Focal
Cerebral Arterial Disease
Vertebral Compression Fractures in Osteoporotic Patients
PET-CT Specimen Imager
Endoleaks
Advanced Bladder Carcinoma
Pain, Breakthrough
Radiofrequency Ablation Treatment
VEXAS Syndrome
Premature Rupture of Membranes Prolonged
Immediate Implant Placement
Failed Induction
Old Age (Focus; Not a Recognized Condition)
Cardiovascular Primary Prevention
Eye Disease, Hereditary
PPA Syndrome
Biomarkers, Pharmacological
SMA - Spinal Muscular Atrophy
Infection, Bacterial
View Full List
Drug Interventions
OXP005
Lacosamide
Microneedling with topical glycolic acid 35%.
TQB2450
Oxymorphone hydrochloride (HCl)
20 mg/kg IV FL-301
Rosuvastatin
INT-747
0.75% Ropivacaine
Cefadroxil until drain removal
Phase B: Triplixam / Elestar HCT
Durvalumab + chemotherapy treatment
18F-FDG
80% oxygen
Olopatadine hydrochloride 0.2%
CJ-12420 200mg + Clarithromycin 500mg
Acetylsalicylic acid
HPN328
CNTO 6785 50 mg
5 FU continuous
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Canada
Contract Research Organizations in El Salvador
Contract Research Organizations in Finland
Contract Research Organizations in France
Contract Research Organizations in Israel
Contract Research Organizations in Jordan
Contract Research Organizations in Kyrgyzstan
Contract Research Organizations in Mauritius
Contract Research Organizations in Mongolia
Contract Research Organizations in Oman
Contract Research Organizations in Switzerland
CRO list by country
CROs in Cameroon
SGS
All CROs in Cameroon
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe